Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir
March 2008
NIOSH Docket Number 120

Beryllium Sensitization

NIOSH has an ongoing program of research on beryllium-related health effects. One of the major goals of this research is to prevent sensitization and chronic beryllium disease (CBD) by developing a better understanding of the exposure factors and work processes associated with increased risk for workers, and to develop effective interventions that will reduce the risk for adverse health effects. NIOSH also conducts genetic research on sensitization and CBD.

Final Document

NIOSH Alert: Preventing Sensitization and Disease from Beryllium Exposure; 2/1/11  [PDF - 21,661 KB]

Materials Under Evaluation

Draft NIOSH Alert, Preventing Chronic Beryllium Disease and Beryllium Sensitization; 02/01/08 [PDF - 6,146 KB]

Notice of Draft Document Available for Public Comment; 73 FR 12179; 03/06/08 [PDF - 534 KB]

Peer Review Comments

Peer Reviewers' Comments – posted December 31, 2009 [PDF - 46 KB]

Response to Peer Reviewers' Comments – posted December 31, 2009 [PDF - 31 KB]

Response to public comments – posted December 31, 2009 [PDF - 9,538 KB]

Submissions in order of receipt

Exhibit 1 - Submission from Welch (CPWR: Center for Construction Research and Training) – 3/11/08 [PDF - 505 KB]

Exhibit 2 - Submission from Hobbs (USEC) - 4/10/08 [PDF - 223 KB]

Exhibit 3 - Submission from Breysse (Division of Environmental Health Engineering, Department of Environmental Health Sciences) - 4/11/08 [PDF - 249 KB]

Exhibit 4 - Submission from private person (1) - 5/05/08 [PDF - 652 KB]

Exhibit 5 - Submission from Woodside (NGK Metals Corporation) - 5/07/08 [PDF - 676 KB]

Exhibit 6 - Submission from Agrawal (AJJER LLC) - 5/12/08 [PDF - 4,188 KB]

Exhibit 7 - Submission from Arnett (Copper and Brass Fabricators Council, Inc.) - 5/12/08 [PDF - 795 KB]

Exhibit 8 - Submission from Wambach (Department of Energy) - 5/12/08 [PDF - 1,658 KB]

Exhibit 9 - Submission from Warner (Caldera Pharmaceuticals, Inc.) - 5/12/08 [PDF - 3,784 KB]

Exhibit 10 - Submission from Vandyke (National Jewish Medical and Research Center) - 5/12/08 [PDF - 2,209 KB]

Exhibit 11 - Submission from Jahn (Savannah River Site) - 5/12/08 [PDF - 27 KB]

Exhibit 12 - Submission from Weeks (Los Alamos National Laboratory) – 5/12/08 [PDF - 14 KB]

Exhibit 13 - Submission from private person (2) - 5/12/08 [PDF - 42 KB]

Exhibit 14 - Submission from private person (3) - 5/12/08 [PDF - 69 KB]

Exhibit 15 - Submission from Kolanz (Brush Wellman Inc.) - 5/12/08 [PDF - 22,322 KB]

Exhibit 16 - Submission from Gildersleeve (NGK Metals Corporation) - 05/30/08 [PDF - 137 KB]

 
Contact Us:
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO